An evaluation method for uric acid uptake inhibition using primary human proximal tubule epithelial cells treated with insulin

References

• Feig, D. I.; Kang, D. H.; Johnson, R. J. Uric Acid and Cardiovascular Risk. N. Engl. J. Med. 2008, 359, 1811–1821.
   PubMed Web of Science ®Google Scholar
• Essex, M. N.; Hopps, M.; Bienen, E. J.; Udall, M.; Mardekian, J.; Makinson, G. T. Evaluation of the Relationship between Serum Uric Acid Levels and Cardiovascular Events in Patients with Gout: A Retrospective Analysis Using Electronic Medical Record Data. J. Clin. Rheumatol. 2017, 23, 160–166. DOI: 10.1097/RHU.0000000000000496.
   PubMed Web of Science ®Google Scholar
• Hisatome, I.; Li, P.; Miake, J.; Taufiq, F.; Mahati, E.; Maharani, N.; Utami, S. B.; Kuwabara, M.; Bahrudin, U.; Ninomiya, H. Uric Acid as a Risk Factor for Chronic Kidney Disease and Cardiovascular Disease – Japanese Guideline on the Management of Asymptomatic Hyperuricemia. Circ. J. 2021, 85, 130–138. DOI: 10.1253/circj.CJ-20-0406.
   PubMed Web of Science ®Google Scholar
• MacIsaac, R. L.; Salatzki, J.; Higgins, P.; Walters, M. R.; Padmanabhan, S.; Dominiczak, A. F.; Touyz, R. M.; Dawson, J. Allopurinol and Cardiovascular Outcomes in Adults with Hypertension. Hypertension. 2016, 67, 535–540. DOI: 10.1161/HYPERTENSIONAHA.115.06344.
   PubMed Web of Science ®Google Scholar
• Boss, G. R.; Seegmiller, J. E. Hyperuricemia and Gout. Classification, Complications and Management. N. Engl. J. Med. 1979, 300, 1459–1468. DOI: 10.1056/NEJM197906283002604.
   PubMed Web of Science ®Google Scholar
• Ichida, K.; Matsuo, H.; Takada, T.; Nakayama, A.; Murakami, K.; Shimizu, T.; Yamanashi, Y.; Kasuga, H.; Nakashima, H.; Nakamura, T.; et al. Decreased Extra-Renal Urate Excretion is a Common Cause of Hyperuricemia. Nat. Commun. 2012, 3, 764.
   PubMed Web of Science ®Google Scholar
• Yamanaka, H. Japanese Society of Gout and Nucleic Acid Metabolism. Japanese Guideline for the Management of Hyperuricemia and Gout: Second Edition. Nucleos. Nucleot. Nucl. 2011, 30, 1018–1029. DOI: 10.1080/15257770.2011.596496.
   PubMed Web of Science ®Google Scholar
• Sato, S.; Tatsumi, K.; Nishino, T. A Novel Xanthine Dehydrogenase Inhibitor (BOF-4272). Purine and Pyrimidine Metabolism in Man VII (Part of the Adv. Exp. Med. Biol.) 1991, 309A, 135–138.
   Google Scholar
• Bobulescu, I. A.; Moe, O. W. Renal Transport of Uric Acid: Evolving Concepts and Uncertainties. Adv. Chronic. Kidney Dis. 2012, 19, 358–371. DOI: 10.1053/j.ackd.2012.07.009.
   PubMed Web of Science ®Google Scholar
• Heel, R. C.; Brogden, R. N.; Speight, T. M.; Avery, G. S. Benzbromarone: A Review of Its Pharmacological Properties and Therapeutic Use in Gout and Hyperuricaemia. Drugs. 1977, 14, 349–366. DOI: 10.2165/00003495-197714050-00002.
   PubMed Web of Science ®Google Scholar
• Taniguchi, T.; Ashizawa, N.; Matsumoto, K.; Saito, R.; Motoki, K.; Sakai, M.; Chikamatsu, N.; Hagihara, C.; Hashiba, M.; Iwanaga, T. Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor. J. Pharmacol Exp. Ther. 2019, 371, 162–170. DOI: 10.1124/jpet.119.259341.
   PubMed Web of Science ®Google Scholar
• Iwanaga, T.; Sato, M.; Maeda, T.; Ogihara, T.; Tamai, I. Concentration-Dependent Mode of Interaction of Angiotensin II Receptor Blockers with Uric Acid Transporter. J. Pharmacol. Exp. Ther. 2007, 320, 211–217. DOI: 10.1124/jpet.106.112755.
   PubMed Web of Science ®Google Scholar
• Enomoto, A.; Kimura, H.; Chairoungdua, A.; Shigeta, Y.; Jutabha, P.; Cha, S. H.; Hosoyamada, M.; Takeda, M.; Sekine, T.; Igarashi, T.; et al. Molecular Identification of a Renal Urate Anion Exchanger That Regulates Blood Urate Levels. Nature. 2002, 417, 447–452. DOI: 10.1038/nature742.
   PubMed Web of Science ®Google Scholar
• Anzai, N.; Miyazaki, H.; Noshiro, R.; Khamdang, S.; Chairoungdua, A.; Shin, H.-J.; Enomoto, A.; Sakamoto, S.; Hirata, T.; Tomita, K.; et al. The Multivalent PDZ Domain-Containing Protein PDZK1 Regulates Transport Activity of Renal Urate-Anion Exchanger URAT1 via Its C Terminus. J. Biol. Chem. 2004, 279, 45942–45950. DOI: 10.1074/jbc.M406724200.
   PubMed Web of Science ®Google Scholar
• Toyoki, D.; Shibata, S.; Kuribayashi-Okuma, E.; Xu, N.; Ishizawa, K.; Hosoyamada, M.; Uchida, S. Insulin Stimulates Uric Acid Reabsorption via Regulating Urate Transporter 1 and ATP-Binding Cassette Subfamily G Member 2. Am. J. Physiol. Renal. Physiol. 2017, 313, F826–F834. DOI: 10.1152/ajprenal.00012.2017.
   PubMed Web of Science ®Google Scholar
• Hoppensack, A.; Kazanecki, C. C.; Colter, D.; Gosiewska, A.; Schanz, J.; Walles, H.; Schenke-Layland, K. A Human In Vitro Model That Mimics the Renal Proximal Tubule. Tissue Eng. Part C. Methods. 2014, 20, 599–609. DOI: 10.1089/ten.TEC.2013.0446.
   PubMed Web of Science ®Google Scholar
• Brown, C. D. A.; Sayer, R.; Windass, A. S.; Haslam, I. S.; De Broe, M. E.; D’Haese, P. C.; Verhulst, A. Characterisation of Human Tubular Cell Monolayers as a Model of Proximal Tubular Xenobiotic Handling. Toxicol. Appl. Pharmacol. 2008, 233, 428–438. DOI: 10.1016/j.taap.2008.09.018.
   PubMed Web of Science ®Google Scholar
• Huls, M.; Brown, C. D. A.; Windass, A. S.; Sayer, R.; van den Heuvel, J. J. M. W.; Heemskerk, S.; Russel, F. G. M.; Masereeuw, R. The Breast Cancer Resistance Protein Transporter ABCG2 is Expressed in the Human Kidney Proximal Tubule Apical Membrane. Kidney Int. 2008, 73, 220–225. DOI: 10.1038/sj.ki.5002645.
   PubMed Web of Science ®Google Scholar
• Prestin, K.; Hussner, J.; Ferreira, C.; Seibert, I.; Breitung, V.; Zimmermann, U.; Meyer Zu Schwabedissen, H. E. Regulation of PDZ Domain-Containing 1 (PDZK1) Expression by Hepatocyte Nuclear Factor-1α (HNF1α) in Human Kidney. Am. J. Physiol. Renal. Physiol. 2017, 313, F973–F983. DOI: 10.1152/ajprenal.00650.2016.
   PubMed Web of Science ®Google Scholar
• Shimada, I.; Iwata, C.; Taga, S.; Teramachi, H.; Nomura, M.; Miyamoto, K.-I.; Tsuciya, H.; Wada, T.; Kimura, K.; Matsushita, R. Enhanced Renal Clearance of Vancomycin in Rats with Carcinogen-Induced Osteosarcoma. Anticancer Res. 2012, 32, 823–829.
   PubMed Web of Science ®Google Scholar
• Uda, J.; Kobashi, S.; Miyata, S.; Ashizawa, N.; Matsumoto, K.; Iwanaga, T. Discovery of Dotinurad (FYU-981), a New Phenol Derivative with Highly Potent Uric Acid Lowering Activity. ACS Med. Chem. Lett. 2020, 11, 2017–2023.
   PubMed Web of Science ®Google Scholar
• Uda, J.; Kobashi, S.; Ashizawa, N.; Matsumoto, K.; Iwanaga, T. Novel Monocyclic Amide-Linked Phenol Derivatives without Mitochondrial Toxicity Have Potent Uric Acid-Lowering Activity. Bioorg. Med. Chem. Lett. 2021, 40, 127900. DOI: 10.1016/j.bmcl.2021.127900.
   PubMed Web of Science ®Google Scholar
• Muscelli, E.; Natali, A.; Bianchi, S.; Bigazzi, R.; Galvan, A. Q.; Sironi, A. M.; Frascerra, S.; Ciociaro, D.; Ferrannini, E. Effect of Insulin on Renal Sodium and Uric Acid Handling in Essential Hypertension. Am. J. Hypertens. 1996, 9, 746–752. DOI: 10.1016/0895-7061(96)00098-2.
   PubMed Web of Science ®Google Scholar
• Facchini, F.; Chen, Y. D.; Hollenbeck, C. B.; Reaven, G. M. Relationship between Resistance to Insulin-Mediated Glucose Uptake, Urinary Uric Acid Clearance, and Plasma Uric Acid Concentration. JAMA. 1991, 266, 3008–3011.
   PubMed Web of Science ®Google Scholar
• Schneeweiss, J.; Poole, G. W. Hyperuricaemia Due to Pyrazinamide. Br. Med. J. 1960, 2, 830–832. DOI: 10.1136/bmj.2.5202.830.
   PubMedGoogle Scholar
• Gopal, E.; Fei, Y. L.; Sugawara, M.; Miyauchi, S.; Zhuang, L.; Martin, P.; Smith, S. B.; Prasad, P. D.; Ganapathy, V. Expression of slc5a8 in Kidney and Its Role in Na(+)-Coupled Transport of Lactate. J. Biol. Chem. 2004, 279, 44522–44532. DOI: 10.1074/jbc.M405365200.
   PubMed Web of Science ®Google Scholar
• Tanaka, Y.; Nagoshi, T.; Takahashi, H.; Oi, Y.; Yoshii, A.; Kimura, H.; Ito, K.; Kashiwagi, Y.; Tanaka, T. D.; Yoshimura, M. URAT1-Selective Inhibition Ameliorates Insulin Resistance by Attenuating Diet-Induced Hepatic Steatosis and Brown Adipose Tissue Whitening in Mice. Mol. Metab. 2022, 55, 101411. DOI: 10.1016/j.molmet.2021.101411.
   PubMed Web of Science ®Google Scholar
• Xu, L.; Shi, Y.; Zhuang, S.; Liu, N. Recent Advances on Uric Acid Transporters. Oncotarget. 2017, 8, 100852–100862. DOI: 10.18632/oncotarget.20135.
   PubMedGoogle Scholar
• Higashino, T.; Morimoto, K.; Nakaoka, H.; Toyoda, Y.; Kawamura, Y.; Shimizu, S.; Nakamura, T.; Hosomichi, K.; Nakayama, A.; Ooyama, K.; et al. Dysfunctional Missense Variant of OAT10/SLC22A13 Decreases Gout Risk and Serum Uric Acid Levels. Ann. Rheum. Dis. 2020, 79, 164–166. DOI: 10.1136/annrheumdis-2019-216044.
   PubMed Web of Science ®Google Scholar